Brainsway Ltd Total Liabilities
Brainsway Ltd total liabilities. Based on the latest financial reports, Brainsway Ltd (BWAY) has total liabilities worth ILA42.79 Million ILA (≈ $114.71K USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check BWAY cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Brainsway Ltd (2012–2025)
Total liabilities of Brainsway Ltd from 2012 to 2025. This chart illustrates how Brainsway Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore long-term investment intensity of Brainsway Ltd to see how much of total assets are deployed in long-term investments.
Brainsway Ltd Competitors by Total Liabilities
The table below lists competitors of Brainsway Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ningxia Xiaoming Agriculture & Animal Husbandry Co.Ltd
SHE:300967
|
China | CN¥838.17 Million |
|
Vishnu Chemicals Limited
NSE:VISHNU
|
India | Rs10.13 Billion |
|
Sports Gear Co. Ltd
TW:6768
|
Taiwan | NT$8.58 Billion |
|
Hung Ching Development & Construction Co Ltd
TW:2527
|
Taiwan | NT$14.47 Billion |
|
SAMPYO Cement Co. Ltd
KQ:038500
|
Korea | ₩660.87 Billion |
|
North American Financial 15
TO:FFN
|
Canada | CA$588.15 Million |
|
Issta Lines Ltd
TA:ISTA
|
Israel | ILA2.29 Billion |
|
Eurocharm Holdings Co Ltd
TW:5288
|
Taiwan | NT$2.27 Billion |
Liability Composition Analysis (2012–2025)
This chart breaks down Brainsway Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Brainsway Ltd asset portfolio.
Liquidity & Leverage Metrics
Brainsway Ltd Total Liabilities Ratios Explained
Brainsway Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.59 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.54 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Brainsway Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Brainsway Ltd (2012–2025)
The table below shows the annual total liabilities of Brainsway Ltd from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ILA34.67 Million ≈ $92.96K |
+8.35% |
| 2024-12-31 | ILA32.00 Million ≈ $85.80K |
+49.61% |
| 2023-12-31 | ILA21.39 Million ≈ $57.35K |
+12.11% |
| 2022-12-31 | ILA19.08 Million ≈ $51.15K |
+3.65% |
| 2021-12-31 | ILA18.41 Million ≈ $49.35K |
+28.04% |
| 2020-12-31 | ILA14.38 Million ≈ $38.54K |
-0.96% |
| 2019-12-31 | ILA14.52 Million ≈ $38.92K |
-12.82% |
| 2018-12-31 | ILA16.65 Million ≈ $44.64K |
+16.36% |
| 2017-12-31 | ILA14.31 Million ≈ $38.36K |
+47.87% |
| 2016-12-31 | ILA9.68 Million ≈ $25.94K |
+3.52% |
| 2015-12-31 | ILA9.35 Million ≈ $25.06K |
-8.30% |
| 2014-12-31 | ILA10.19 Million ≈ $27.33K |
+219.03% |
| 2013-12-31 | ILA3.20 Million ≈ $8.57K |
+90.21% |
| 2012-12-31 | ILA1.68 Million ≈ $4.50K |
-- |
About Brainsway Ltd
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, … Read more